Literature DB >> 19798556

Provision of genetic services for hearing loss: results from a national survey and comparison to insights obtained from previous focus group discussions.

Kara Anne Withrow1, Kelly A Tracy, Sarah K Burton, Virginia W Norris, Hermine H Maes, Kathleen S Arnos, Arti Pandya.   

Abstract

Hearing loss is a common sensory deficit and more than 50% of affected individuals have a genetic etiology. The discovery of 40 genes and more than 100 loci involved in hearing loss has made genetic testing for some of these genes widely available. Genetic services for deafness are also being sought more often due to the early identification of hearing loss through newborn screening services. The motivations for pursuing genetic testing, and how genetic services are provided to the client may differ among individuals. Additionally, information obtained through genetic testing can be perceived and used in different ways by parents of deaf children and deaf adults. This study aimed to follow up on focus group studies published earlier with a quantitative survey instrument and assess the preference of consumers for provision of genetic services. We conducted a national survey of hearing and deaf parents of children with hearing loss and of deaf adults. Data was compared and analyzed by hearing status of the participant, their community affiliation and the genetic testing status using nominal logistic regression. Consistent with our focus group results, the survey participants thought that a genetic counselor/geneticist would be the most appropriate professional to provide genetics services. Statistically significant differences were noted in the preferred choice of provider based on the genetic testing status. Parents preferred that genetic evaluation, including testing, occur either immediately at or a few months after the audiologic diagnosis of hearing loss. This data should help providers in clinical genetics keep patient preferences at the helm and provide culturally competent services.

Entities:  

Mesh:

Year:  2009        PMID: 19798556     DOI: 10.1007/s10897-009-9246-8

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  3 in total

1.  Impact of genetic advances and testing for hearing loss: results from a national consumer survey.

Authors:  Kara A Withrow; Kelly A Tracy; Sarah K Burton; Virginia W Norris; Hermine H Maes; Kathleen S Arnos; Arti Pandya
Journal:  Am J Med Genet A       Date:  2009-06       Impact factor: 2.802

2.  Consumer motivations for pursuing genetic testing and their preferences for the provision of genetic services for hearing loss.

Authors:  Kara A Withrow; Sarah Burton; Kathleen S Arnos; Andrea Kalfoglou; Arti Pandya
Journal:  J Genet Couns       Date:  2008-02-05       Impact factor: 2.537

3.  A focus group study of consumer attitudes toward genetic testing and newborn screening for deafness.

Authors:  Sarah K Burton; Kara Withrow; Kathleen S Arnos; Andrea L Kalfoglou; Arti Pandya
Journal:  Genet Med       Date:  2006-12       Impact factor: 8.822

  3 in total
  3 in total

1.  Deaf adults' reasons for genetic testing depend on cultural affiliation: results from a prospective, longitudinal genetic counseling and testing study.

Authors:  Patrick Boudreault; Erin E Baldwin; Michelle Fox; Loriel Dutton; Leeelle Tullis; Joyce Linden; Yoko Kobayashi; Jin Zhou; Janet S Sinsheimer; Yvonne Sininger; Wayne W Grody; Christina G S Palmer
Journal:  J Deaf Stud Deaf Educ       Date:  2010-05-20

2.  Effect of pre-test genetic counseling for deaf adults on knowledge of genetic testing.

Authors:  Erin E Baldwin; Patrick Boudreault; Michelle Fox; Janet S Sinsheimer; Christina G S Palmer
Journal:  J Genet Couns       Date:  2011-08-05       Impact factor: 2.537

3.  Impact of genetic counseling and Connexin-26 and Connexin-30 testing on deaf identity and comprehension of genetic test results in a sample of deaf adults: a prospective, longitudinal study.

Authors:  Christina G S Palmer; Patrick Boudreault; Erin E Baldwin; Janet S Sinsheimer
Journal:  PLoS One       Date:  2014-11-06       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.